BioAro Inc.

07.08.2025 - 18:04:29

BioAro Inc to Host Inaugural Longevity Innovation Forum in Dubai, UAE

that uses computer vision and advanced cameras for early disease detection.

The roundtable discussion will be moderated by Fady Hannah-Shmouni, MD DABIM FRCPC, clinical endocrinologist, geneticist, Professor of Medicine at the University of British Columbia, and Founder/CEO of Healthspan Digital Inc, known for his expertise in rare endocrine disorders, hypertension and personalized medicine.

The Longevity Innovation Forum will delve into various topics, including the latest breakthroughs in precision health and longevity medicine, the impact of genetics on healthy aging, and the challenges and opportunities in developing effective interventions for extending human lifespan.

"We are thrilled to host the inaugural Longevity Innovation Forum in Dubai," said Dr. Anmol Kapoor, Founder and CEO of BioAro Inc. "This event will serve as a significant platform for leading experts and visionaries to exchange ideas, collaborate, and shape the future of healthy aging and longevity medicine. We believe that by bringing together the brightest minds in the field, we can accelerate advancements and drive positive change in the pursuit of longer, healthier lives."

Attendance at the Longevity Innovation Forum is by invitation only, with limited spots available for industry professionals, researchers, investors, and stakeholders interested in the field of longevity medicine. For more information and registration details, please visit the official event website at www.BioAro.com

About BioAro Inc:
BioAro Inc. is a Canadian biotechnology company dedicated to precision health and longevity medicine. With a focus on cutting-edge research, innovative technologies, and strategic collaborations, BioAro Inc is committed to advancing the understanding and application of precision medicine for a better and healthier future.